Exposure to glyphosate—the world's most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup—increases the risk of some cancers by more than 40 percent, according to new research ...
Feb 14, 2019
1
40
To reduce your risk of cancer, you know you should quit smoking, exercise regularly, wear sunscreen, and take advantage of screening tests. New research suggests another item might be added to this list: Choose organic foods ...
Oct 22, 2018
0
658
For just the second time ever an HIV patient is in sustained remission from the virus in what was hailed by experts Tuesday as proof that the AIDS-causing condition could one day be curable.
Mar 5, 2019
0
562
People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.
Dec 1, 2017
0
354
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the ...
Nov 19, 2021
0
21
(HealthDay)—Prurigo nodularis (PN) is associated with mental health disorders, systemic illnesses, and HIV infection, according to a study published online Aug. 15 in the Journal of Investigative Dermatology.
Aug 23, 2019
0
11
The common weed killer Roundup (glyphosate) is back in the news after a US court ruled it contributed to a man's terminal cancer (non-Hodgkin lymphoma). Following the court's order for manufacturer Monsanto to compensate ...
Oct 8, 2018
1
9
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer ...
Dec 5, 2020
0
187
(Medical Xpress)—Two groups of researchers have published articles in the journal Biology Letters, suggesting that it's time we stop blaming cats for making people crazy or for a certain type of brain cancer that other ...
A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly ...
Jun 4, 2023
0
54
